Trypanosomiasis Global Clinical Trials Review, H1, 2013

GlobalData
March 31, 2013
92 Pages - SKU: GBDT5014101
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
10/7/2014 | published by: GlobalData
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In  |  read more...
USD 3,995
Legionella Control (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Legionella Control (UK) analysis is the most definitive and accurate study of the UK Legionella Control (UK) sector in 2014. The report is split into two sections and uses both a written and graphical  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s Biotechnology (UK) analysis is the most definitive and accurate study of the Biotechnology (UK) sector in 2014. The report is split into two sections and uses both a written and graphical analysis – analysing the  |  read more...
USD 1,520
Clinical Trails Market in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
Clinical Trails Market in India - 2014 This report provides an insight into the Clinical Trails current market scenario, structure and practices in India. In depth market scenario includes; Market estimate of Clinical Trails in India for FY14 Share  |  read more...
USD 4,000
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014
10/7/2014 | published by: GlobalData
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario.  |  read more...
USD 2,500
KOL Insight: Multiple Sclerosis
10/6/2014 | published by: FirstWord
Introduction Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will  |  read more...
USD 6,495
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
10/15/2014 | published by: GlobalData
Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity,  |  read more...
USD 3,995
Pericarditis Global Clinical Trials Review, H2, 2014
9/21/2014 | published by: GlobalData
Pericarditis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pericarditis Global Clinical Trials Review, H2, 2014 provides data on the Pericarditis clinical trial scenario. This report provides elemental information and data relating to the  |  read more...
USD 2,500
Clinical Research in the United Kingdom
10/2/2014 | published by: Plimsoll Publishing Ltd.
UK Clinical Research Analysis displays a summary of the UK Clinical Research market and presents a comprehensive individual analysis on the top 110 companies, including SCHERING-PLOUGH LTD, NAPP PHARMACEUTICAL GROUP LTD and QUOTIENT CLINICAL LTD.  |  read more...
USD 525
Medical Market Research in the United Kingdom
10/2/2014 | published by: Plimsoll Publishing Ltd.
UK Medical Market Research Analysis displays a summary of the UK Medical Market Research market and presents a comprehensive individual analysis on the top 40 companies, including MILLWARD BROWN UK LTD, MATHEMATICAL MARKET RESEARCH LTD  |  read more...
USD 525
 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!